laser | GenomeWeb

laser

The anticipated weak mass-spec market has not stopped vendors from launching new instruments, which may pay off later in the year when spending from the economic stimulus package could hit instrument manufacturers.

Proteomics

The firm also said that it and NextGen Sciences have developed a protein biomarker assay method that can provide rapid, reproducible, quantitative measurement of protein expression in formalin-fixed, paraffin-embedded tissue.

The AB Sciex TOF/TOF 5800, which the companies said enables researchers to identify 30 percent more proteins and speed up the biomarker discovery process 10-fold, follows platform launches in the fall meant to put them back at the top of the mass-spec food chain.

Patents

Premium

Sequencing-Related US Patents Granted March 4 – April 2

The firms will combine their respective technologies to develop and sell new products for high-throughput protein profiling and identification.

News Scan

Premium

CompuCyte, Children's Hospital Boston, US Senate, National Institutes of Health, Albert Einstein College of Medicine, Empire State Stem Cell Board, MDS, Caliper Life Sciences, CHDI, GlobalStem, ADMEcell, Advancell

Papers of Note

Premium

RNAi-Related Papers Published Feb. 2009

The Houston-based startup plans to commercialize the reagents, called Lightning Terminators, for use with at least one existing sequencing platform. Long term, it wants to develop its own sequencing instrument for applications in personalized genomics.

IP Roundup

Premium

Seiko Epson, SRU Biosystems, University of California, Roche NimbleGen, Illumina

Pages

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.